Your browser doesn't support javascript.
loading
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy.
Babapoor-Farrokhran, Savalan; Jee, Kathleen; Puchner, Brooks; Hassan, Syed Junaid; Xin, Xiaoban; Rodrigues, Murilo; Kashiwabuchi, Fabiana; Ma, Tao; Hu, Ke; Deshpande, Monika; Daoud, Yassine; Solomon, Sharon; Wenick, Adam; Lutty, Gerard A; Semenza, Gregg L; Montaner, Silvia; Sodhi, Akrit.
Afiliação
  • Babapoor-Farrokhran S; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287;
  • Jee K; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287;
  • Puchner B; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287;
  • Hassan SJ; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287;
  • Xin X; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287;
  • Rodrigues M; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287;
  • Kashiwabuchi F; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287;
  • Ma T; Department of Oncology and Diagnostic Sciences, School of Dentistry, and Department of Pathology, School of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, MD 21201;
  • Hu K; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287; Department of Ophthalmology, The First Affiliated Hospital of Chongqing Medical University, 400016 Chongqing, China.
  • Deshpande M; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287;
  • Daoud Y; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287;
  • Solomon S; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287;
  • Wenick A; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287;
  • Lutty GA; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287;
  • Semenza GL; Vascular Program, Institute for Cell Engineering, and Departments of Pediatrics, Medicine, Oncology, Radiation Oncology, Biological Chemistry, and Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205;
  • Montaner S; Department of Oncology and Diagnostic Sciences, School of Dentistry, and Department of Pathology, School of Medicine, Greenebaum Cancer Center, University of Maryland, Baltimore, MD 21201;
  • Sodhi A; Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287; asodhi1@jhmi.edu.
Proc Natl Acad Sci U S A ; 112(23): E3030-9, 2015 Jun 09.
Article em En | MEDLINE | ID: mdl-26039997
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Angiopoietinas / Retinopatia Diabética Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Angiopoietinas / Retinopatia Diabética Idioma: En Ano de publicação: 2015 Tipo de documento: Article